Analysis of the role of Bphs/Hrh1 in the genetic control of responsiveness to pertussis toxin

Infection and Immunity

Volumn 71, Issue 3, 2003, Pages 1281-1287

  Gao, Jian Feng ^a   Call, Stanford B ^a   Fillmore, Parley D ^b   Watanabe, Takeshi ^c   Meeker, Nathan D ^d   Teuscher, Cory ^a,e  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c KYUSHU UNIVERSITY   (Japan)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; HISTAMINE H1 RECEPTOR; PERTUSSIS TOXIN; SEROTONIN; VASOACTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BLOOD VESSEL FUNCTION; BLOOD VESSEL PERMEABILITY; BORDETELLA PERTUSSIS; BPHS GENE; CAUSE OF DEATH; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE PREDISPOSITION; GENE CONTROL; GENE IDENTIFICATION; GENE LOCUS; GLUCOSE METABOLISM; HRH1 GENE; IN VIVO STUDY; INTOXICATION; LEUKOCYTOSIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SENSITIZATION;

ANIMALS; BLOOD GLUCOSE; CAPILLARY PERMEABILITY; EPINEPHRINE; GENETIC PREDISPOSITION TO DISEASE; HISTAMINE; HYPERSENSITIVITY, DELAYED; LEUKOCYTOSIS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; PERTUSSIS TOXIN; RECEPTORS, HISTAMINE H1; SEROTONIN;

EID: 0037369746     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.3.1281-1287.2003     Document Type: Article

References (48)

1. Amiel, S. A. 1976. The effects of Bordetella pertussis vaccine on cerebral vascular permeability. Br. J. Exp. Pathol. 57:653-662.
2. Anderson, I. M., and D. Morris. 1950. Encephalopathy after combined diphtheria-pertussis inoculation. Lancet 1:537.
3. Badr el Din, M. K., G. H. Aref, H. Mazloum, Y. A. el-Towsey, A. S. Kassem, M. A. Abdel-Moneim, and A. A. Abbassy. 1976. The beta-adrenergic receptors in pertussis. J. Trop. Med. Hyg. 79:213-217.
4. Bebo, B. F., T. Yong, E. L. Orr, and D. S. Linthicum. 1996. Hypothesis: a possible role for mast cells and their inflammatory mediators in the pathogenesis of autoimmune encephalomyelitis. J. Neurosci. Res. 45:340-348.
5. Belcher, C. E., J. Drenkow, B. Kehoe, T. R. Gingeras, N. McNamara, H. Lemjabbar, C. Basbaum, and D. A. Relman. 2000. The transcriptional response of respiratory epithelial cells to Bordetella pertussis reveals host defensive and pathogen counter-defensive strategies. Proc. Natl. Acad. Sci. USA 97:13847-13852.
6. Bergman, R. K., and J. J. Munoz. 1969. Hypoglycemia and its relationship to histamine sensitization in mice. Proc. Soc. Exp. Biol. Med. 131:42-46.
7. Blumberg, D. A., K. Lewis, C. M. Mink, P. D. Christenson, P. Chatfield, and J. D. Cherry. 1993. Severe reactions associated with diphtheria-tetanuspertussis vaccine: detailed study of children with seizures, hypotonic-hyporesponsive episodes, high fevers, and persistent crying. Pediatrics 91:1158-1165.
8. Boldrick, J. C., A. A. Alizadeh, M. Diehn, S. Duobit, C. L. Liu, C. E. Belcher, D. Botstein, L. M. Staudt, P. O. Brown, and D. A. Relman. 2002. Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc. Natl. Acad. Sci. USA 99:972-977.
9. Bordet, J., and O. Gengou. 1906. Le microbe de la coqueluche. Ann. Inst. Pasteur 20:731-741.
10. el Baya, A., K. Bruckener, and M. A. Schmict. 1999. Nonrestricted differential intoxication of cells by pertussis toxin. Infect. Immun. 67:433-435.
11. Furman, B. L., E. Walker, F. M. Sidey, and A. C. Wardlaw. 1988. Slight hyperinsulinemia but no hypoglycemia in pertussis patients. J. Med. Microbiol. 25:183-186.
12. Furman, B. L., F. M. Sidey, and M. Smith. 1988. Metabolic disturbances produced by pertussis toxin, p. 147-172. In A. C. Wardlaw and R. Parton (ed.), Pathogenesis and immunity in pertussis. John Wiley and Sons, Ltd., Chichester, United Kingdom.
13. Globus, J. H., and J. L. Kohn. 1949. Encephalopathy following pertussis vaccine prophylaxis. JAMA 141:507.
14. Hannik, C. A., and H. Cohen. 1979. Changes in plasma insulin concentration and temperature of infants after pertussis vaccination, p. 297-299. In C. R. Manclark and J. C. Hill (ed.), International symposium on pertussis. U.S. DHEW publication no. (NIH)79-1830. U.S. Department of Health, Education, and Welfare, Washington, D.C.
15. Hattori, R., K. K. Hamilton, R. D. Fugates, R. P. McEver, and P. J. Sims. 1989. Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution of the cell surface of the intracellular granule membrane protein GMP-140. J. Biol. Chem. 264:7768-7771.
16. Hennessen, W., and U. Quast. 1979. Adverse reactions after pertussis vaccination. Dev. Biol. Stand. 43:95-100.
17. Hofstetter, H. H., C. L. Shive, and T. G. Forsthuber. 2002. Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells. J. Immunol. 169:117-125.
18. Holt, L. B., V. Spasojevic, J. M. Dolby, and A. T. B. Standfast. 1961. Immunity in mice to an intracerebral challenge of Bordetella pertussis. J. Hyg. 59:373-379.
19. Kaslow, H. R., and D. L. Burns. 1992. Pertussis toxin and target eukaryotic cells: binding, entry, and activation. FASEB J. 6:2684-2690.
20. Khare, S., K. Gokulan, and D. S. Linthicum. 2000. Vasoactive amine responses in murine cerebrovascular endothelial cells as measured by extracellular acidification rates. J. Neurosci. Res. 60:356-361.
21. Linthicum, D. S. 1982. Development of acute autoimmune encephalomyelitis in mice: factors regulating the effector phase of the disease. Immunobiology 162:211-220.
22. Linthicum, D. S., and J. A. Frelinger. 1982. Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes. J. Exp. Med. 156:31-40.
23. Linthicum, D. S., J. J. Munoz, and A. Blaskett. 1982, Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system. Cell. Immunol. 73:299-310.
24. Locht, C. 1999. Molecular aspects of Bordetella pertussis pathogenesis. Int. Microbiol. 3:137-144.
25. 1. Science 297:620-623.
26. Morse, S. I., and J. H. Morse. 1976. Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis. J. Exp. Med. 143:1483-1502.
27. Munoz, J. J. 1985. Biological activities of pertussigen (pertussis toxin), p. 1-18. In R. D. Sekura, J. Moss, and M. Vaughan (ed.), Pertussis toxin. Academic Press, Orlando, Fla.
28. Munoz, J. J., and R. K. Bergman. 1968. Histamine-sensitizing factors from microbial agents, with special reference to Bordetella pertussis. Bacteriol. Rev. 32:103-126.
29. Munoz, J. J., and R. K. Bergman. 1977. Bordetella pertussis: immunological and other biological activities. Immunol. Ser. 4:1-235.
30. Munoz, J. J., H. Arai, R. K. Bergman, and P. L. Sadowski. 1981. Biological activities of crystalline pertussigen from Bordetella pertussis. Infect. Immun. 33:820-826.
31. Rappuoli, R., and M. Pizza, 1991. Structure and evolutionary aspects of ADP-ribosylating toxins, p. 1-20. In J. Abuf and J. Freer (ed.), Source book of bacterial protein toxins. Academic Press, London, United Kingdom.
32. Regan, J. C., and A. Tolstoouhov. 1936. Relations of acid base equilibrium to the pathogenesis and treatment of whooping cough. N. Y. State J. Med. 36:1075-1087.
33. Ryan, M., L. McCarthy, R. Rappuoli, B. P. Mahon, and K. H. Mills. 1998. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28. Int. Immunol. 10:651-662.
34. Schluter, T., and R. Bohnensack. 1999. Serotonin-induced secretion of von Willebrand factor from human umbilical vein endothelial cells via tile cyclic AMP-signaling systems independent of increased cytoplasmic calcium concentration. Biochem. Pharmacol. 57:1191-1197.
35. Sewell, W. A., J. J. Munoz, and M. A. Vadas. 1983. Enhancement of the intensity, persistence, and passive transfer of delayed-type hypersensitivity lesions by pertussigen in mice. J. Exp. Med. 157:2087-2096.
36. Sewell, W. A., J. J. Munoz, R. Scollary, and M. A. Vadas. 1984. Studies on the mechanism of the enhancement of delayed-type hypersensitivity by pertussigen. J. Immunol. 133:1716-1722.
37. Sewell, W. A., P. A. de Moerloose, J. L. McKimm-Breschkin, and M. A. Vadas. 1986. Pertussigen enhances antigen-driven interferon-γ production by sensitized lymphoid cells. Cell. Immunol. 97:238-247.
38. Shive, C. L., H. Hofstetter, L. Arredondo, C. Shaw, and T. G. Forsthuber. 2000. The enhanced antigen-specific production of cytokines induced by pertussis toxin is due to clonal expansion of T cells and not to altered effector function of long-term memory cells. Eur. J. Immunol. 30:2422-2431.
39. Sudweeks, J. D., J. A. Todd, E. P. Blankenhorn, B. B. Wardell, S. R. Woodward, N. D. Meeker, S. S. Estes, and C. Teuscher. 1993. Locus controlling Bordetella pertussis-induced histamine sensitization (Bphs), an autoimmune disease-susceptibility gene, maps distal to T-cell receptor β-chain gene on mouse chromosome 6. Proc. Natl. Acad. Sci. USA 90:3700-3704.
40. Taub, R. N., W. Rosett, A. Adler, and S. I. Morse. 1972. Distribution of labeled lymph cells in mice during the lymphocytosis induced by Bordetella pertussis. J. Exp. Med. 136:1581-1593.
41. Utgaard, J. O., F. L Jahnsen, A. Bakka, P Brandtzaeg, and G. Haraldsen. 1998. Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells. J. Exp. Med. 188:1751-1756.
42. Vas, N. M., C. M. de Souza, L. C. S. Maia, and D. G. Hanson. 1977. Effects of Bordetella pertussis on the sensitivity of inbred mice to vasoactive amines. Int. Arch. Allergy Appl. Immunol. 53:560-568.
43. Wardlaw, A. C. 1970. Inheritance and responsiveness to pertussis HSF in mice. Int. Arch. Allergy Appl. Immunol. 38:573-580.
44. Wardlaw, A. C., and R. Parton. 1983. Bordetella pertussis toxin. Pharmacol. Ther. 19:1-53.
45. Wolff, B., A. R. Burns, J. Middleton, and A. Rot. 1998. Endothelial cell "memory" of inflammatory stimulation: human venular endothelial cells store interleukin 8 in Weibel-Palade bodies. J. Exp. Med. 188:1757-1762.
46. Yong, T., and D. S. Linthicum. 1996. Microvascular leakage in mouse pial venules induced by bradykinin. Brain Inj. 10:385-393.
47. Yong, T., B. F. Bebo, B. V. Sapatino, C. J. Welsh, E. L. Orr, and D. S. Linthicum. 1994. Histamine-induced microvascular leakage in pial venules: differences between the SJL/J and BALB/c inbred strains of mice. J. Neuroimmunol. 11:161-171.
48. Yong, T., G. A. Meininger, and D. S. Linthicum. 1993. Enhancement of histamine-induced vascular leakage by pertussis toxin in SJL/J mice but not BALB/c mice. J. Neuroimmunol. 45:47-52.